DPP4 and type 2 diabetes mellitus: Other promising new approaches including DPP4 inhibitors were tested over a 12-week period and have proven improvements in beta cell function and insulin resistance with lower conversion rates to T2DM (111) in the combined DPP4 inhibitor and lifestyle intervention group compared with lifestyle intervention alone.